(Q40402286)

20 September 2017

title

Cost-effectiveness of varicella vaccination of healthcare workers (English)

1 reference

20 September 2017

1

Gabriel Chodick

1 reference

20 September 2017

2

Shai Ashkenazi

1 reference

20 September 2017

Gilat Livni

3

1 reference

20 September 2017

Yehuda Lerman

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

23

1 reference

20 September 2017

issue

43

1 reference

20 September 2017

page(s)

5064-5072

1 reference

An algorithm for the control of nosocomial varicella-zoster virus infection

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Chicken pox outbreak in staff and students of a hospital in the tropics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Economic evaluations of varicella vaccination programmes: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

An economic analysis of varicella vaccination for health care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Varicella vaccine: the Japanese experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

A long-term prospective study of varicella vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

The cost-effectiveness of routine childhood varicella vaccination in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Impact and costs of varicella prevention in a university hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Screening healthcare workers for varicella-zoster virus: can we trust the history?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Varicella zoster antibodies in healthcare workers from two neonatal units in São Paulo, Brazil--assessment of a staff varicella policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Strategies for the management of varicella-susceptible healthcare workers after a known exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Varicella and paediatric staff: current practice and vaccine cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

A cluster of primary varicella cases among healthcare workers with false-positive varicella zoster virus titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Controlling varicella in the healthcare setting: barriers to varicella vaccination among healthcare workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

The effectiveness of the varicella vaccine in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Cost effectiveness of vaccination strategies in adults without a history of chickenpox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

A cost-effectiveness model for analyzing two varicella vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Cost containment analysis of childhood vaccination against varicella in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Management of varicella-vaccinated patients and employees exposed to varicella in the healthcare setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Chickenpox outbreak among the staff of a large, urban adult hospital: costs of monitoring and control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Immunisation of nurses with a live varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Varicella serological status of healthcare workers as a guide to whom to test or immunize

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Susceptibility to varicella zoster virus infection in health care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Use of a computerized database to study the effectiveness of an attenuated varicella vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

7 January 2021

Varicella Vaccine Update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.004

10.1016/J.VACCINE.2005.06.004

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference